Search results for: 'research area tyrosine kinase insulin receptor'
- A3735 PreladenantTarget: Adenosine A2A ReceptorsSummary: Adenosine A2A receptor antagonist
- A3778 RS 127445Summary: 5-HT2B receptor antagonist,high affinity
- B7848 RS 127445 HClSummary: 5-HT2B receptor antagonist,high affinity
- A3885 TozadenantTarget: Adenosine A2A ReceptorsSummary: Adenosine 2a receptor antagonist,novel and selective
- BA6330 LazertinibSummary: A potent, reversible, orally available, blood-brain barrier-crossing, mutant-selective, third-generation tyrosine kinase inhibitor.
- BA8864 BezuclastinibSummary: Bezuclastinib (CGT9486) is an orally active, highly selective tyrosine kinase inhibitor with potent anti-activity.
- BA8876 ZongertinibSummary: Zongertinib (BI1810631) is a potent, selective and tyrosine kinase inhibitor with values of 13nM and 579nM, respectively.
- B7764 HNGF6ASummary: increases glucose stimulated insulin secretion and glucose metabolism
- B5261 Xenin 8Summary: neurotensin-like peptide that modulate pancreatic insulin and glucagon secretion/effects
- BA8979 AGL-2263Summary: Inhibitors of insulin receptors and insulin-like growth factor receptors.